Friday, May 29, 2020

Urgently Responding to This Outbreak, Vigilantly Preparing for the Next

With the outbreak of COVID-19, the WuXi AppTec community is committed to helping the world pivot from fear to determination and effective action. On February 25, in an effort...

Tackling COVID-19 at a Potential Achilles Heel, siRNA: A Conversation with Alnylam’s CEO...

Having recent success in lung delivery, short interfering RNA (siRNA) is poised to be a powerful new modality to treat COVID-19. Alnylam and Vir Biotechnology expanded their 2017 partnership...

Click is Pioneering and Developing Cutting-edge Digital Therapeutics to Transform Medicine

What is digital health? In broad terms, it is the convergence of digital technologies with medicine, health and society to boost treatment efficacy and deliver more personalized and precise...

Apitope’s Research Seeks to Put Cause of Multiple Sclerosis into Remission

The National Organization of Rare Diseases (NORD) describes multiple sclerosis (MS) as a chronic neuroimmunologic disorder involving the brain, spinal cord and optic nerves. MS is just one of...

Vaccinex’s Cancer Research May Lead to Effective Treatment for Deadly Huntington’s Disease

Huntington's disease (HD), also known as Huntington's chorea, is an inherited genetic disorder that kills brain cells. The Huntington Disease Society of America describes the disease as “a fatal genetic disorder that...

SUBSCRIBE TO OUR NEWSLETTER

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WuXi NEWS